ATHALTERITY THERAPEUTICS LIMITEDMarket sensitive

ATH Receives A$3.98m R&D Tax Incentive

Date and time: 10 July 2026 at 1:52 am
Announcement type: Periodic Reports

Show details

Category: Reports
Report codes: 03014
Sector: Health Care
Industry group: Pharmaceuticals, Biotechnology & Life Sciences

Recent ATH announcements